Company Financials

Avidity Biosciences, Inc. Financials

United States dollar

business Avidity Biosciences, Inc. Company Profile

Main Stock Listing

NASDAQ: RNA

Market Capitalization $10.86 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE -24.95
Forward PE -14.75
Price to Sales TTM $520.81
Price to Book MRQ $5.61
Enterprise to Revenue 433.31
Enterprise to EBITDA -14.85

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 0.00%
Operating Margin -1513.47%
Return on Assets TTM -20.28%
Return on Equity TTM -32.44%

Income Statement

Revenue TTM $20,868,000
Revenue per Share TTM $0.16
Quarterly Revenue Growth 434.00%
Gross Profit TTM $-467,320,000
EBITDA $-609,062,016
Net Income to Common TTM $-549,787,008
Diluted EPS TTM $-4.19
Quarterly Earnings Growth YoY 434.03%

Balance Sheet

Total Cash MRQ $1,875,836,032
Total Cash per Share MRQ $12.45
Total Debt MRQ $
Total Debt to Equity MRQ 2.65
Current Ratio MRQ 11.57
Book Value per Share MRQ $12.85

Cash Flow

Operating Cash Flow TTM $-580,539,008
Levered Free Cash Flow TTM $-301,068,384

RNA Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 146,771,000
Float Shares 128,515,861
Avg 10 Volume 1,863,810
Avg 30 Volume None
Shares Short 9,740,063
Short Ratio 3.86
Short % of Shares 6.51%
% Held by Insiders 4.14%
% Held by Institutions 104.15%

Stock Price Summary

Beta 0.91
Fifty Two Week Low $21.51
Fifty Two Week High $72.61
Fifty Two Week Change 56.42%
Day 50 MA $69.29
Day 200 MA $44.42

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date